iDoctus
iDoctus is a Madrid-based clinical decision support platform that delivers a verified, offline-capable mobile and web app with drug information, interaction checking, medical calculators, and weekly clinical updates to 600,000+ Spanish-speaking physicians via a subscription model.
- Company typePrivate
- Founded2011
- HeadquartersMadrid, Spain
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
What iDoctus does
iDoctus is a clinical decision support platform serving Spanish-speaking physicians through a mobile-first application suite (iOS, Android, and web). Founded around 2011 and headquartered in Madrid, the company provides drug information search with predictive lookup, active principle profiles, severity-classified drug interaction checking, indications/contraindications databases, up to 100 medical calculators (including a pediatric dosing tool), and dedicated knowledge centers for pediatrics, vaccines, emergencies, and toxicology. Content is curated and verified by an internal physician team, with 100+ new translated scientific items published each week. The app is verified-physician-only, functions fully offline, and is positioned as independent of pharmaceutical company influence.
The platform has grown to 600,000+ registered physicians and processes approximately 2.5 million medication searches per month, with distribution handled primarily through self-serve downloads on the Apple App Store and Google Play Store. Revenue is generated through subscription-based access for medical professionals, though specific pricing tiers are not publicly disclosed. Go-to-market is product-led: physicians discover, verify credentials, download, and adopt the app with peer recommendations driving organic spread within the medical community. Distribution is effectively global via app stores, with the Spanish-language focus anchoring adoption in Spain and Latin America.
In June 2022, iDoctus received investment from M3.com, the Japanese healthcare platform operator, and the company's recruiting page is hosted at careers.eu.m3.com, indicating iDoctus operates as part of M3's European footprint. The company remains a private, independent operating entity with no public listing, disclosed venture backing beyond M3, or parent-company acquisition explicitly stated. Operating headcount is in the 11-50 range, consistent with a focused product team supported by medical content specialists.
iDoctus firmographics
Firmographics- Name
- iDoctus
- Legal name
- iDoctus
- Website
- https://iDoctus.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- iDoctus is a Madrid-based clinical decision support platform that delivers a verified, offline-capable mobile and web app with drug information, interaction checking, medical calculators, and weekly clinical updates to 600,000+ Spanish-speaking physicians via a subscription model.
- Ownership category
- akta.pro rank
iDoctus industry classification
Industry- Product category
- Clinical Decision Support Software
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Edge-Based Clinical Decision Support & Alerts (On-Device/On-Prem Analytics) (HLACAPAL)
Keywords
Where iDoctus is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Markets served
iDoctus business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Professional Subscription: The company provides a mobile application for medical professionals with verified medical information. Based on the professional focus and app-based delivery model, revenue is likely generated through subscription-based access for physicians, though specific pricing tiers are not publicly disclosed.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Professional medical reference access for verified physicians |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
iDoctus product offering
Product offeringCore offering
iDoctus is a clinical decision support mobile and web application for Spanish-speaking physicians that provides instant access to verified medication information, drug interaction checking, active principle profiles, indications and contraindications, pediatric dosing calculations, and up to 100 medical calculators. The platform is restricted to verified physicians and functions fully offline, with weekly scientific content updates curated by an internal medical team and specialty-specific Knowledge Centers for pediatrics, vaccines, emergencies, and primary care.
Product overview
iDoctus is a unified medical reference platform for Spanish-speaking physicians, consisting of mobile apps (iOS and Android), a web app, and integrated features including drug search, active ingredient databases, drug interaction checking, medical calculators (up to 100), pediatric dosing tools, knowledge centers (pediatrics, vaccines, emergencies, TEAM), clinical updates (100+ new content pieces weekly), and clinical challenges. The platform operates with verified physician-only users and functions fully offline. Core products are the iDoctus App (available on iOS and Android) and the iDoctus Web App, with all features accessible within this unified ecosystem.
Differentiator
Problem solved
Functional benefit
Products and services
- iDoctus App (iOS)
Quantifiable outcome
- 600,000+ registered physicians actively using the platform
- +4 more outcomes
Companies that use iDoctus
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
iDoctus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature11 records
iDoctus partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights5 records
iDoctus competitors and assessment
Company assessmentDirect peers
- VisualDx: VisualDx is a clinical decision support system focused on visual diagnosis and differential diagnosis, used by physicians at the point of care. It is comparable as a peer clinical decision support tool with physician-targeted delivery, though focused on a visual diagnostics niche.
- Epocrates: Epocrates is a widely-used mobile drug reference and clinical decision support app for physicians, providing drug information, interaction checking, and dosing calculators. It directly competes with iDoctus in physician-facing clinical reference, though Epocrates focuses primarily on the US English-speaking market.
- Medscape: Medscape is a leading global medical reference platform for physicians offering drug information, clinical tools, medical news, and CME. It is a direct peer with multi-language support including Spanish, competing with iDoctus for physician mindshare in Spanish-speaking markets.
- MDCalc: MDCalc provides clinical calculators and decision tools widely used by physicians at the point of care. It directly overlaps with iDoctus's medical calculator functionality, though MDCalc is calculator-focused rather than a full drug reference platform.
- DynaMed: DynaMed is an evidence-based clinical reference tool for physicians providing point-of-care decision support. It is comparable to iDoctus in serving physician clinical decision support workflows, with hospital system distribution models.
- PEPID: PEPID is a clinical decision support and drug reference platform for healthcare professionals offering drug interactions, dosing, and clinical content. It is comparable to iDoctus in providing point-of-care reference tools to physicians.
- Drugs.com: Drugs.com is a widely-used consumer and professional drug information database with interaction checking and pill identifiers. It is comparable to iDoctus for medication lookup and interaction checking, though it is English-centric and targets both professionals and consumers.
Broad incumbents
- UpToDate: UpToDate is a large, evidence-based clinical decision support resource used by physicians worldwide. It is a broad incumbent offering deeper clinical content beyond drug reference and is increasingly used in hospital settings where iDoctus could also compete.
Others
- M3.com (parent): M3.com is the parent company of iDoctus and a major Japanese healthcare platform operating physician portals, medical information services, and clinical decision tools globally. It is comparable as the parent and ecosystem that defines iDoctus's strategic direction and resource base.
Regional players
- Vademecum: Vademecum is a Spanish-language drug reference resource widely used by healthcare professionals in Spain and Latin America. It is a regional peer of iDoctus in the Spanish-speaking physician drug information market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
iDoctus social profiles
Digital presenceiDoctus financial estimates
Financial estimateRevenue estimate
Valuation estimate
iDoctus leadership team
Management profileNumber of profiles
Profiles2 records
iDoctus funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iDoctus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iDoctus
What does iDoctus do?
iDoctus is a clinical decision support mobile and web application for Spanish-speaking physicians that provides instant access to verified medication information, drug interaction checking, active principle profiles, indications and contraindications, pediatric dosing calculations, and up to 100 medical calculators. The platform is restricted to verified physicians and functions fully offline, with weekly scientific content updates curated by an internal medical team and specialty-specific Knowledge Centers for pediatrics, vaccines, emergencies, and primary care.
Is iDoctus a public or private company?
iDoctus is a private company. It is classified as corporate owned and is currently operating.
When was iDoctus founded?
iDoctus was founded in 2011. It employs 11 to 50 people.
Where is iDoctus based?
iDoctus is headquartered in Madrid, Spain, in the Europe region.
How does iDoctus make money?
One revenue line is on record: medical Professional Subscription.
Who are iDoctus's main competitors?
Direct peers on record are VisualDx, Epocrates, Medscape, MDCalc, DynaMed, PEPID and Drugs.com. UpToDate is listed as a broad incumbent. M3.com (parent) is listed as an others. Vademecum is listed as a regional player.
Does iDoctus have an API?
No public API is recorded for iDoctus.
What industry is iDoctus in?
iDoctus's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAPAL, Edge-Based Clinical Decision Support & Alerts (On-Device/On-Prem Analytics). Its SIC code is 7372.